Intrinsic Edge Capital Management’s Inspire Medical Systems INSP Stock Holding History

Intrinsic Edge Capital Management’s Portfolio INSP Stock Details INSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-32,185	Closed	-$4.31M	–	143
2024 Q2	$4.31M	Sell	32,185 -1,753	-5%	-$332K	0.39%	86
2024 Q1	$7.29M	Sell	33,938 -148,908	-81%	-$29.2M	0.57%	64
2023 Q4	$37.2M	Buy	182,846 +126,475	+224%	+$20.5M	3.72%	2
2023 Q3	$11.2M	Buy	56,371 +46,455	+468%	+$11.7M	1.26%	26
2023 Q2	$3.22M	Buy	+9,916	New	+$2.83M	0.23%	126
2021 Q3	–	Sell	-20,000	Closed	-$3.87M	–	242
2021 Q2	$3.87M	Buy	+20,000	New	+$3.97M	0.23%	151

Other funds holding INSP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Intrinsic Edge Capital Management's INSP Position: Q3 2024 in Review

Intrinsic Edge Capital Management sold out of Inspire Medical Systems (INSP) in Q3 2024, closing a stake of 32,185 shares — an estimated $4.31M sold.

Intrinsic Edge Capital Management first reported a position in INSP in Q2 2021 and held it in 6 quarters. The position peaked at $37.2M in Q4 2023. 346 funds tracked by Wall St. Rank hold INSP as of Q3 2024.

Intrinsic Edge Capital Management reported no remaining Inspire Medical Systems position as of Q3 2024 after selling out during the quarter.
Intrinsic Edge Capital Management sold 32,185 Inspire Medical Systems shares in Q3 2024, an estimated $4.31M.
Intrinsic Edge Capital Management first reported a position in Inspire Medical Systems in Q2 2021 and held it in 6 quarters.
Intrinsic Edge Capital Management's Inspire Medical Systems position peaked at $37.2M in Q4 2023.
346 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q3 2024.

Based on Intrinsic Edge Capital Management's 13F filing for Q3 2024, filed 8 Nov 2024.